Medindia
Advertisement

FDA Clears Fibrin Sealant Patch, It Controls Heavy Bleeding in Adult Liver Surgeries

by Julia Samuel on April 7, 2015 at 2:55 PM
Font : A-A+

FDA Clears Fibrin Sealant Patch, It Controls Heavy Bleeding in Adult Liver Surgeries

EVARREST Fibrin Sealant Patch, developed by Ethicon, a part of Johnson & Johnson, received FDA clearance. The patch was designed to be used to help control bleeding during adult liver surgeries. It contains human thrombin and fibrinogen proteins that participate in clot formation and is bio absorbable.

The EVARREST patch had a nearly double improvement in ability to stop bleeding in difficult to control bleeding regions. It retains its strength and stickiness while it's still around, and eases the difficulty while handling liver surgery.

Advertisement

"The liver is a particularly hard-to-control bleed site during surgery, as blood loss is often higher and hemostasis may be difficult to achieve," said Krishna Athota, M.D, trauma and critical care surgeon at the University of Cincinnati College of Medicine.

Clinical studies demonstrate that EVARREST is greater than 94% effective compared to current standard of care in controlling bleeding across challenging patient types and surgical situations.

"This expanded indication for EVARREST reinforces this innovation's potential to make problematic bleeding situations routine, and could result in a paradigm shift in the treatment of bleeding during surgery," he added.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Hepatitis A Liver Wilson's Disease Menorrhagia von Willebrand Disease Hemophilia Milk Thistle Current Treatments for Liver Cancer Fatty Liver Disease: A Growing Health Problem in India Living Donor Liver Transplant: What Are the Risks? 

Recommended Reading
Fatty Liver Disease: A Growing Health Problem in India
Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and .....
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to ....
Current Treatments for Liver Cancer
Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result ...
Hemophilia
Hemophilia is a rare single gene, X- linked disorder, which tends to run in families....
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Living Donor Liver Transplant: What Are the Risks?
The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk ...
Menorrhagia
Menorrhagia is a condition where a woman has menstrual periods that are heavy or prolonged and cause...
Milk Thistle
Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication ...
von Willebrand Disease
von Willebrand's Disease (vWD) is an autosomal dominant inherited bleeding disorder that occurs from...
Wilson's Disease
This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before o...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use